nr |
titel |
type |
1 |
Pharmaceuticals policy and law, vol. 14, no. 1 (2012-02-07)
|
aflevering |
2 |
Pharmaceuticals policy and law, vol. 11, no. 1-2 (2009-03-10)
|
aflevering |
3 |
Pharmaceuticals policy and law, vol. 16, no. 1-2 (2014-06-16)
|
aflevering |
4 |
Pharmaceuticals policy and law, vol. 12, no. 1-2 (2010-10-07)
|
aflevering |
5 |
Pharmaceuticals policy and law, vol. 13, no. 1-2 (2011-07-01)
|
aflevering |
6 |
Pharmaceuticals policy and law, vol. 17, no. 1-2 (2015-04-16)
|
aflevering |
7 |
Pharmaceuticals policy and law, vol. 15, no. 1-2 (2013-12-09)
|
aflevering |
8 |
Pharmaceuticals policy and law, vol. 19, no. 1-2 (2017-4-1)
|
aflevering |
9 |
Pharmaceuticals policy and law, vol. 20, no. 1-4 (2018-12-20)
|
aflevering |
10 |
Pharmaceuticals policy and law, vol. 18, no. 1-4 (2016-10-9)
|
aflevering |
11 |
Pharmaceuticals policy and law, vol. 14, no. 2-4 (2013-02-08)
|
aflevering |
12 |
Pharmaceuticals policy and law, vol. 11, no. 3 (2009-09-24)
|
aflevering |
13 |
Pharmaceuticals policy and law, vol. 9, no. 3-4 (2008-01-15)
|
aflevering |
14 |
Pharmaceuticals policy and law, vol. 12, no. 3-4 (2011-01-19)
|
aflevering |
15 |
Pharmaceuticals policy and law, vol. 13, no. 3-4 (2011-11-01)
|
aflevering |
16 |
Pharmaceuticals policy and law, vol. 16, no. 3-4 (2014-10-20)
|
aflevering |
17 |
Pharmaceuticals policy and law, vol. 15, no. 3-4 (2014-01-07)
|
aflevering |
18 |
Pharmaceuticals policy and law, vol. 17, no. 3-4 (2016-2-15)
|
aflevering |
19 |
Pharmaceuticals policy and law, vol. 19, no. 3-4 (2018-10-17)
|
aflevering |
20 |
Pharmaceuticals policy and law, vol. 11, no. 4 (2009-09-03)
|
aflevering |